Drug reference

teprotumumab-trbw

Mosby’s 2024 Nursing Drug Reference

Source: Mosby’s 2024 Nursing Drug Reference
PDF pages: 1272

Overview

Names and pronunciation

(tep′roe-toom′ue-mab) Tepezza

PDF page 1272

Functional class

Func. class.: Insulin-like growth fac- tor-1 antagonist

PDF page 1272

Uses

USES: Treatment of thyroid eye disease

PDF page 1272

Safety

Contraindications

CONTRAINDICATIONS: Hypersensitivity

PDF page 1272

Dose and formulations

Dosage and routes

DOSAGE AND ROUTES Thyroid eye disease • Adult: IV: 10 mg/kg as a single dose, then 20 mg/kg q3wk × 7 more doses

PDF page 1272

Available forms

Available forms: Powder for injection 500 mg

PDF page 1272

Dose text by age group

Adult

• Adult: IV: 10 mg/kg as a single dose, then 20 mg/kg q3wk × 7 more doses

PDF page 1272

Age labels are extracted for navigation. Check the complete source section and current local guidance before clinical use.

Drug reference

teprotumumab-trbw

Mosby’s 2024 Nursing Drug Reference

Source: Mosby’s 2024 Nursing Drug Reference
PDF pages: 1272

Overview

Names and pronunciation

(tep′roe-toom′ue-mab) Tepezza

PDF page 1272

Functional class

Func. class.: Insulin-like growth fac- tor-1 antagonist

PDF page 1272

Uses

USES: Treatment of thyroid eye disease

PDF page 1272

Safety

Contraindications

CONTRAINDICATIONS: Hypersensitivity

PDF page 1272

Dose and formulations

Dosage and routes

DOSAGE AND ROUTES Thyroid eye disease • Adult: IV: 10 mg/kg as a single dose, then 20 mg/kg q3wk × 7 more doses

PDF page 1272

Available forms

Available forms: Powder for injection 500 mg

PDF page 1272

Dose text by age group

Adult

• Adult: IV: 10 mg/kg as a single dose, then 20 mg/kg q3wk × 7 more doses

PDF page 1272

Age labels are extracted for navigation. Check the complete source section and current local guidance before clinical use.